As of April 15, 2025, Sinopharm (1099.HK) has a market cap of $3.04 billion USD. According to our data, Sinopharm is ranked No.3325 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 15, 2025 | $3.04 B |
-18.04%
|
Dec 31, 2024 | $3.71 B |
9.64%
|
Dec 29, 2023 | $3.38 B |
6.78%
|
Dec 30, 2022 | $3.17 B |
22.50%
|
Dec 31, 2021 | $2.59 B |
-6.88%
|
Dec 31, 2020 | $2.78 B |
-31.56%
|
Dec 31, 2019 | $4.06 B |
-11.36%
|
Dec 31, 2018 | $4.58 B |
-0.45%
|
Dec 29, 2017 | $4.60 B |
7.30%
|
Dec 30, 2016 | $4.29 B |
4.12%
|
Dec 31, 2015 | $4.12 B |
14.52%
|
Dec 31, 2014 | $3.60 B |
25.32%
|
Dec 31, 2013 | $2.87 B |
-7.14%
|
Dec 31, 2012 | $3.09 B |
31.34%
|
Dec 30, 2011 | $2.35 B |
-30.74%
|
Dec 31, 2010 | $3.40 B |
-1.60%
|
Dec 31, 2009 | $3.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() Merck
MRK
|
$197.26 B |
0.003 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
![]() UK
|
![]() Sanofi
SNY
|
$123.58 B |
-0.002 M
|
![]() France
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioNTech
BNTX
|
$23.80 B |
0.001 M
|
![]() Germany
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
Market Cap | = | 1099.HK Stock Price | * | 1099.HK Shares Outstanding |
= | $2.27 | * | 1.34 B | |
= | $3.04 B |